BRPI0922972A2 - Processo de preparo de ésteres ativados. - Google Patents

Processo de preparo de ésteres ativados.

Info

Publication number
BRPI0922972A2
BRPI0922972A2 BRPI0922972-8A BRPI0922972A BRPI0922972A2 BR PI0922972 A2 BRPI0922972 A2 BR PI0922972A2 BR PI0922972 A BRPI0922972 A BR PI0922972A BR PI0922972 A2 BRPI0922972 A2 BR PI0922972A2
Authority
BR
Brazil
Prior art keywords
preparation
activated esters
esters
activated
Prior art date
Application number
BRPI0922972-8A
Other languages
English (en)
Inventor
Antony Bigot
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BRPI0922972A2 publication Critical patent/BRPI0922972A2/pt
Publication of BRPI0922972A8 publication Critical patent/BRPI0922972A8/pt
Publication of BRPI0922972B1 publication Critical patent/BRPI0922972B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • C07D213/71Sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0922972-8A 2008-12-17 2009-12-15 Processo de preparação de ésteres ativados, bem como sal de diciclohexilamina BRPI0922972B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0807090A FR2939795B1 (fr) 2008-12-17 2008-12-17 Procede de preparation d'esters actives
FR08/07090 2008-12-17
PCT/FR2009/052528 WO2010076474A1 (fr) 2008-12-17 2009-12-15 Procede de preparation d'esters actives

Publications (3)

Publication Number Publication Date
BRPI0922972A2 true BRPI0922972A2 (pt) 2015-08-11
BRPI0922972A8 BRPI0922972A8 (pt) 2018-02-06
BRPI0922972B1 BRPI0922972B1 (pt) 2021-06-01

Family

ID=40614691

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922972-8A BRPI0922972B1 (pt) 2008-12-17 2009-12-15 Processo de preparação de ésteres ativados, bem como sal de diciclohexilamina

Country Status (25)

Country Link
US (1) US8314244B2 (pt)
EP (1) EP2379501B1 (pt)
JP (1) JP5467111B2 (pt)
KR (1) KR101645051B1 (pt)
CN (1) CN102292318B (pt)
AU (1) AU2009334689B2 (pt)
BR (1) BRPI0922972B1 (pt)
CA (1) CA2747105C (pt)
CY (1) CY1115035T1 (pt)
DK (1) DK2379501T3 (pt)
ES (1) ES2459918T3 (pt)
FR (1) FR2939795B1 (pt)
HR (1) HRP20140368T1 (pt)
IL (1) IL213525A (pt)
ME (1) ME01827B (pt)
MX (1) MX2011006624A (pt)
MY (1) MY156761A (pt)
PL (1) PL2379501T4 (pt)
PT (1) PT2379501E (pt)
RS (1) RS53267B (pt)
RU (1) RU2506258C2 (pt)
SG (1) SG172179A1 (pt)
SI (1) SI2379501T1 (pt)
SM (1) SMT201400061B (pt)
WO (1) WO2010076474A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963007B1 (fr) 2010-07-26 2013-04-05 Sanofi Aventis Derives anticancereux, leur preparation et leur application therapeutique
US10436790B2 (en) 2011-09-28 2019-10-08 Waters Technologies Corporation Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals
US11352325B2 (en) 2011-09-28 2022-06-07 Waters Technologies Corporation Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals
JP6774748B2 (ja) * 2014-08-13 2020-10-28 ウオーターズ・テクノロジーズ・コーポレイシヨン 強められたms信号を有するグリカンおよび他の生体分子の迅速蛍光タグ付け
EP3213056B1 (en) 2014-10-30 2020-08-12 Waters Technologies Corporation Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same
WO2016077548A1 (en) 2014-11-13 2016-05-19 Waters Technologies Corporation Methods for liquid chromatography calibration for rapid labeled n-glycans
US11035832B2 (en) 2016-06-21 2021-06-15 Waters Technologies Corporation Methods of electrospray ionization of glycans modified with amphipathic, strongly basic moieties
EP3472132A4 (en) 2016-06-21 2020-01-15 Waters Technologies Corporation FLUORESCENCE LABELING OF GLYCANS AND OTHER BIOMOLECULES BY REDUCING AMINATION FOR IMPROVED MASS SPECTROMETRY SIGNALS
EP3479103B1 (en) 2016-07-01 2022-04-20 Waters Technologies Corporation Methods for the rapid preparation of labeled glycosylamines from complex matrices using molecular weight cut off filtration and on-filter deglycosylation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5710101B2 (pt) * 1972-10-24 1982-02-24
US5892057A (en) 1997-09-18 1999-04-06 Pierce Chemical Company Preparation of sulfo-N-hydroxysuccinimide salts
US5872261A (en) 1997-09-18 1999-02-16 Pierce Chemical Company Preparation of sulfo-N- hydroxy succinimide salts with intermediate formation of diester
JP2002316987A (ja) * 2001-04-20 2002-10-31 Sankyo Co Ltd 2−アルコキシベンゼン誘導体を含有する医薬
DE60336149D1 (de) * 2002-08-16 2011-04-07 Immunogen Inc Vernetzer mit hoher reaktivität und löslichkeit und ihre verwendung bei der herstellung von konjugaten für die gezielte abgabe von kleinmolekularen arzneimitteln
JP4929461B2 (ja) * 2004-10-29 2012-05-09 国立大学法人富山大学 高蛍光量子収率型疎水性蛍光プローブ、それを用いる生体高分子検出法ならびに生体高分子間相互作用検出法
ATE472560T1 (de) * 2004-11-09 2010-07-15 Basf Se N-substituierte imide als polymerisatiosinitiatoren
US8871720B2 (en) * 2005-07-07 2014-10-28 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus

Also Published As

Publication number Publication date
SMT201400061B (it) 2014-07-07
ES2459918T3 (es) 2014-05-12
US8314244B2 (en) 2012-11-20
KR20110094311A (ko) 2011-08-23
SG172179A1 (en) 2011-07-28
KR101645051B1 (ko) 2016-08-02
IL213525A (en) 2014-11-30
AU2009334689B2 (en) 2015-10-08
MY156761A (en) 2016-03-31
RU2011129652A (ru) 2013-01-27
ME01827B (me) 2014-12-20
JP5467111B2 (ja) 2014-04-09
DK2379501T3 (da) 2014-04-28
EP2379501A1 (fr) 2011-10-26
US20110313168A1 (en) 2011-12-22
CA2747105A1 (fr) 2010-07-08
CY1115035T1 (el) 2016-12-14
BRPI0922972A8 (pt) 2018-02-06
FR2939795B1 (fr) 2010-12-17
CN102292318B (zh) 2014-01-01
HK1163664A1 (zh) 2012-09-14
EP2379501B1 (fr) 2014-01-22
PL2379501T3 (pl) 2014-07-31
IL213525A0 (en) 2011-07-31
CA2747105C (fr) 2017-02-28
SI2379501T1 (sl) 2014-05-30
MX2011006624A (es) 2011-11-04
AU2009334689A1 (en) 2011-07-07
JP2012512234A (ja) 2012-05-31
HRP20140368T1 (hr) 2014-06-20
BRPI0922972B1 (pt) 2021-06-01
CN102292318A (zh) 2011-12-21
RS53267B (sr) 2014-08-29
PL2379501T4 (pl) 2014-12-31
PT2379501E (pt) 2014-05-02
WO2010076474A1 (fr) 2010-07-08
FR2939795A1 (fr) 2010-06-18
RU2506258C2 (ru) 2014-02-10

Similar Documents

Publication Publication Date Title
BRPI0821944A2 (pt) Processo
BRPI0919868A2 (pt) processo
SMT201400100B (it) Processo migliorato
BRPI0921374A2 (pt) processo
EP2289050A4 (en) SHADER INTERFACES
BR112012000822A2 (pt) processo
BRPI0910854A2 (pt) métodos de tratamento
BRPI0906764A2 (pt) Processos
BRPI1007829A2 (pt) processo de separação
BR112012012338A2 (pt) processo
BRPI0919090A2 (pt) prepraração de ácido acético.
PT2165971T (pt) Processo de hidrotratamento
BRPI0920540A2 (pt) método de produção de álcool
BRPI0917575A2 (pt) métodos de tratamento de talassemia
BRPI0908725A2 (pt) Processo enzimático
BRPI0922972A2 (pt) Processo de preparo de ésteres ativados.
BRPI1012134A2 (pt) processo de carbolinação
BRPI0909422A2 (pt) conjunto de artigos.
BRPI1010553A2 (pt) processo de carbonilação.
BRPI1007573A2 (pt) processo
FI20085693A0 (fi) Biosignaalin prosessointi
DE112009002122A5 (de) Beschichtungsverfahren
BR112012029016A2 (pt) processo de redução direta
BRPI1010643A2 (pt) processo de hidroformilação
BRPI0914871A2 (pt) Processo enzimático

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: SANOFI (FR)

B25A Requested transfer of rights approved

Owner name: IMMONUGEN, INC. (US)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/12/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2859 DE 21-10-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.